| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.026 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |